Short description
Cerespir is an operator of a biotechnology company intended to treat neurodegenerative disorders.
Description
Cerespir is a operator of a biotechnology company intended to treat neurodegenerative disorders. The company focuses on a novel class of pharmacological agents known as AICD inhibitors and they act by preventing the destructive cycle of neuroinflammation and neurodegeneration which is initiated by chronic oxidative stress, enabling physicians to treat neurodegenerative diseases such as Parkinson and Alzheimer.
Total funding
$$3123123
Sign in for full access
Location
New York, New York, United States, North America
Founded on
January 1, 2013
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Founders
Daniel Chain